Connect with us

Uncategorized

Varsity develops herbal anti-diabetic, anti-cancer drugs – VC

Published

on

Varsity develops herbal anti-diabetic, anti-cancer drugs – VC

Dr Salihu Department of the Biochemistry, Federal Unversity Dutse (FUD), Jigawa, has developed a herbal anti-diabetic and anti-cancer drugs.


The Vice-Chancellor of the university, Prof. Fatima Batul-Muktar, disclosed this at a newsmen conference in Dutse on Monday.


“I am glad to inform you that one of our staff, Dr Salihu Ibrahim Isma’il of the Biochemistry Department has developed a herbal anti-diabetic and anti-cancer drugs,” Fatima-Batul said.


The vice chancellor said that the anti-diabetic drug has successfully passed a pre-clinical stage.


She added that it has also gotten ethical approval for clinical trial by Kano State Hospitals Management Board (KSHMB).

Varsity develops herbal anti-diabetic, anti-cancer drugs – VC


According to her, the clinical trial will soon commence at Muhammad Abdullahi Wase Specialist Hospital (MAWSH), Kano.


Batul-Muktar, who identified research as one of the important works of a university, noted the varsity’s academic staffers have successfully completed 16 research works in different fields since its establishment in 2011, adding “19 research works are currently ongoing”.


According to Batul-Muktar, the Tertiary Education Trust Fund (Tetfund), has released N178, 956, 970 million to the varsity for Academic Staff Training and Development (AST&D).


She further revealed that 11 academic staff are currently on local fellowship pursuing their PhDs, six on foreign scholarship and 17 academic staff have benefitted from conference attendance. 

 

Facebook Comments Box

Copyright 2022 ROYAL NEWS. All rights reserved. Digital material on this website, may not be published, reproduced, broadcast, rewritten or redistributed in whole or in part without prior express written permission from ROYAL NEWS.

Contact: info@royalnews.com.ng

Download ROYAL NEWS app

Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *